Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Biotechnology

Intellia Therapeutics

Intellia Therapeutics' headquarters in Cambridge, MA, United States

John Leonard

Stephanie Williams

David Lebwohl

Birgit Schultes

Kathleen Shea

Maria Natale

Edward Dulac

Yong Chang

Jessica Seitzer

Aron Stein

James Basta

Marika St. Amand

Jesse Goodman

Jennifer Doudna

Fred Cohen

Georgia Keresty

Bill Chase

Brian Goff

Frank Verwiel

Nessan Bermingham

Luciano Marraffini

Andy May

Derrick Rossi

Erik Sontheimer

Muna Bhanji

This department focuses on scientific research and development, employing scientists to conduct experiments and analyze data.

Research Science

This department oversees regulatory compliance, medical communications, drug safety, and clinical operations to ensure the effective development and management of medical products.

Regulatory and Medical Affairs

The Scientific and Technical Positions team at Intellia Therapeutics is dedicated to advancing genome editing technologies through a multidisciplinary approach. This team, comprising engineers, scientists, and computational experts, collaboratively designs, develops, and optimizes processes and tools essential for the discovery and manufacture of innovative gene therapies. Their work is pivotal in transforming scientific research into viable treatment options for severe diseases.

Scientific and Technical Positions

This department oversees the execution and administration of clinical operations, data management, and regulatory affairs to ensure compliance and efficiency in clinical programs.

Clinical Operations and Management

The Research and Development team at Intellia Therapeutics is dedicated to advancing innovative genome editing therapies aimed at treating severe and life-threatening diseases. This multidisciplinary group conducts cutting-edge research, manages clinical trials, and collaborates on product planning and regulatory strategies to ensure the safe and effective development of new gene editing treatments. Their expertise spans pharmacovigilance, biostatistics, assay development, and supply chain management, driving the progression of therapies from concept to clinical application.

Research and Development

This department oversees and manages business operations and strategies to drive organizational growth.

Business Management

Intellia Therapeutics

Org chart

Board & advisors

Teams

Research Science

Regulatory and Medical Affairs

Scientific and Technical Positions

Clinical Operations and Management

Research and Development

Business Management

Offices

Intellia Therapeutics

Org chart

Board & advisors

Teams

Research Science

Regulatory and Medical Affairs

Scientific and Technical Positions

Clinical Operations and Management

Research and Development

Business Management

Offices

Related companies